Skip to main content
logo
Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.190
+0.025 (2.15%)
Sep 9, 2026, 6:08 PM HKT

Cloudbreak Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
0.270.2510.210.880.47
Revenue Growth
6.32%-97.52%1060.68%86.84%-
Gross Profit
0.270.2510.210.880.47
Operating Income
-121.85-107.18-37.22-37.88-23.69
Net Income
-120.79-67.66-99.13-129.42-66.84
Earnings Per Share
-0.14-0.10-0.21-0.28-0.15
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
44.8358.3534.8660.1579.11
Total Debt
6.430.76386.71323110.8
Net Cash (Debt)
38.457.59-351.84-262.85-31.69
Net Cash Growth
-33.32%----
Net Cash Per Share
0.050.09-0.74-0.57-0.07

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
--51.54-26.52-22.51-20.05
Capital Expenditures
--0.2-0.16-0.56-0.78
Free Cash Flow
--51.74-26.68-23.06-20.83
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-45298.14%-42363.24%-364.43%-4304.20%-5029.09%
Pretax Margin
-44971.75%-26788.14%-962.38%-14703.98%-14173.25%
Profit Margin
-44904.46%-26743.08%-970.53%-14706.59%-14190.66%
FCF Margin
--20449.01%-261.18%-2620.68%-4422.08%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
476.432215.23---